TidalSense
Mark Gleeson is an accomplished executive with extensive experience in the healthcare sector. Currently serving as Chief Commercial Officer at TidalSense since April 2023, Mark also holds the position of Director at Brantridge Healthcare Management since March 2020. Mark co-founded The Day Surgery and Treatment Group from January 2020 to October 2022 and previously worked at Sodexo as Director Of Business Development for Healthcare UK&I until December 2020. Prior roles include Business Director: PET-CT and Commercial Marketing Director at InHealth, Head of Sales and Marketing at Spire Healthcare, and Commercial Director at Abbeyfield. Mark's career began at Smith and Nephew Healthcare as Sales and Marketing Manager and Strategic Partnership Manager. Mark holds an MBA from Hult Ashridge Executive Education, earned between 2008 and 2009.
This person is not in any teams
This person is not in any offices
TidalSense
TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company headquartered in Cambridge UK. TidalSense builds AI-driven diagnostic and monitoring solutions for respiratory medicine built on the foundation of the company's novel patented sensor technology, N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, rapid sampled CO2, unlike anything seen before in clinical medicine.